Intertek highlight assay optimization at the Immunogenicity and Bioassay Summit

Meet our team at the Ninth Annual Immunogenicity and Bioassay Summit, October 23-26, Washington, DC, United States

Intertek’s Alena Nikolskaya, Senior Scientist, Cell Based Assays, Intertek Pharmaceutical Services, will present an abstract titled “Drug Tolerance Improvement in Cell Based NAb Assays using Pharmacokinetic Assay Data”.

Meet the Intertek team during the conference and share the latest industry insights on how we can overcome your challenges for large molecule pharmaceutical development. Visit us in Booth #4 to learn how our immunochemistry facility in San Diego, California can help you meet your milestones in safety and efficacy studies through Immunochemistry Services, Immunogenicity Assays, Biosimilars Testing Services, Cell-Based Neutralization Assays, Ligand-Binding Assays and Quantitative Immunoassays.

Intertek is a world leading provider of immunochemistry and biomarker services for bioanalytical studies supporting the preclinical and clinical development of protein based therapeutics and other biologic medicines.

Request a meeting

Learn More About the 2017 Immunogenicity and Bioassay Summit
The Ninth Annual Immunogenicity and Bioassay Summit will cover Immunogenicity Assessment, Prediction and Risk Mitigation, and Bioanalytical and Bioassay Development. New this year is a focus on Bioassays for Immuno-Oncology, Immunology for Scientists in Biotherapeutic Discovery and Development, and an Introduction to Design of Experiments. The 2017 summit features more than 250 global attendees, 75 scientific presentations and case studies, panel discussions, short courses and training seminars. 
Need help or have a question? +1-858-558-2599
 

Need help or have a question?

+1-858-558-2599
EMEA UK:
+44 161 721 5247